LAUSR

PAS-D fi Neuro fi lament The patient was treated with 2 g ceftriaxone intravenously for 2 weeks, followed by 100 mg doxycycline twice daily and 200 mg hydroxychloroquine 3 times per day for 1 year. Response to therapy is being evaluated by improvements in weight gain, insomnia, arthritis, and neurological symptoms. Initially, slight improvements were reported in insomnia, mental acuity, and mood. The patient was referred to physical therapy and speech therapy. As of this report, pro-gress in therapy has slowed, and the patient has again experienced confusion, falls, and worsening neurological symptoms similar to his presenting complaints.